User profiles for Gustavo Roversi

Gustavo Roversi

Medical Student at the Cleveland Clinic Lerner College of Medicine
Verified email at ccf.org
Cited by 568

Myeloid-derived suppressor cell subsets drive glioblastoma growth in a sex-specific manner

…, C Park, C Hong, D Vail, DJ Silver, A Lauko, G Roversi… - Cancer discovery, 2020 - AACR
Sexual dimorphism at the level of MDSC subset prevalence, localization, and gene-expression
profile constitutes a therapeutic opportunity. Our results indicate that chemotherapy can …

[HTML][HTML] Glioblastoma myeloid-derived suppressor cell subsets express differential macrophage migration inhibitory factor receptor profiles that can be targeted to …

…, A Rabljenovic, L Leng, L Jia-Shiun, G Roversi… - Frontiers in …, 2020 - frontiersin.org
The application of tumor immunotherapy to glioblastoma (GBM) is limited by an unprecedented
degree of immune suppression due to factors that include high numbers of immune …

[HTML][HTML] Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells

…, AG Alvarado, B Otvos, D Bayik, G Roversi… - JCI insight, 2019 - ncbi.nlm.nih.gov
BACKGROUND Myeloid-derived suppressor cells (MDSCs) are elevated in the circulation
of patients with glioblastoma (GBM), present in tumor tissue, and associated with poor …

[HTML][HTML] Severe consequences of a high-lipid diet include hydrogen sulfide dysfunction and enhanced aggression in glioblastoma

DJ Silver, GA Roversi, N Bithi, SZ Wang… - The Journal of …, 2021 - Am Soc Clin Investig
Glioblastoma (GBM) remains among the deadliest of human malignancies, and the
emergence of the cancer stem cell (CSC) phenotype represents a major challenge to durable …

ADAMDEC1 maintains a growth factor signaling loop in cancer stem cells

…, A Kordowski, J Pugh, DJ Silver, D Bayik, G Roversi… - Cancer discovery, 2019 - AACR
Cancer stem cells (CSC) drive tumor growth in many cancers including GBM. We identified
a novel sheddase, ADAMDEC1, which initiates an FGF autocrine loop to promote stemness …

What happens to the preserved renal parenchyma after clamped partial nephrectomy?

…, Z Zhou, K Ning, N Jia, J Nie, D Wen, Z Wu, G Roversi… - European Urology, 2022 - Elsevier
Background Most partial nephrectomies (PNs) are performed with hilar occlusion to reduce
blood loss and optimize visualization. However, the histologic status of the preserved renal …

Adrenal steroids and resistance to hormonal blockade of prostate and breast cancer

P Michael, G Roversi, K Brown, N Sharifi - Endocrinology, 2023 - academic.oup.com
Prostate cancer and breast cancer are sex-steroid–dependent diseases that are driven in
major part by gonadal sex steroids. Testosterone (T) is converted to 5α-dihydrotestosterone, …

WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma

…, DJ Silver, CM Goins, L Wallace, G Roversi… - Genes & …, 2023 - genesdev.cshlp.org
Glioblastomas (GBMs) are heterogeneous, treatment-resistant tumors driven by populations
of cancer stem cells (CSCs). However, few molecular mechanisms critical for CSC …

Does reduced renal function predispose to cancer-specific mortality from renal cell carcinoma?

DA Palacios, EC Zabor, C Munoz-Lopez, G Roversi… - European Urology, 2021 - Elsevier
Background Recent publications have reported an association between increased renal
cancer-specific mortality (CSM) and reduced renal function “below safety limits,” and advocated …

[HTML][HTML] Point of care parenchymal volume analyses to estimate split renal function and predict functional outcomes after radical nephrectomy

…, W Attawettayanon, Y Yasuda, K Lewis, G Roversi… - Scientific Reports, 2023 - nature.com
Accurate prediction of new baseline GFR (NBGFR) after radical nephrectomy (RN) can
inform clinical management and patient counseling whenever RN is a strong consideration. …